Appeared hemostatic device within 20 seconds

When used, these absorbent tablets will expand 10 times larger and block the wound, preventing haemorrhage in less than 20 seconds.

Scientists have successfully developed ultra-fast hemostatic devices

The hemostatic device for 20 seconds in the form of a US military special syringe has been approved by the US Food and Drug Administration (FDA) for civilian use instead of just compacted. inside the hospital at the battlefield. With normal wounds taking 3 or 4 minutes to stop bleeding completely, this device has a pretty promising future when widely applied to Americans.

In the name of XStat 30 , this device is capable of sealing open wounds that are dangerous due to shot or stabbing. It is useful for wounds in places where the gauze cannot hold, such as under the armpit or near the perineal.

XStat is not suitable for injuries that appear in some dangerous areas.

This hemostatic device is made by RevMedx medical equipment company, officially used in the military in April 2015. This invention can be said to be a savior for soldiers on the battlefield, because haemorrhage is the leading cause of death among combat participants.

XStat includes a plastic cylinder with a diameter of 30mm and 92 special absorbent tablets, each with a size of 9.8mm and is capable of absorbing 3ml of blood. When used, these absorbent tablets will expand 10 times larger and block the wound, preventing haemorrhage in less than 20 seconds.Absorbent tablets are made of synthetic cellulose, which is wrapped with chitosan - which helps increase blood clotting and infection resistance. They can replace cotton bandages within 4 hours, giving patients enough time to go to the hospital for surgery.

With the "nod" of FDA, XStat is now approved for use in public health in the United States. This unique device will be a timely salvage plan for those who suffer from serious accidents or are attacked by weapons of damage. According to FDA statistics, nearly 50% of soldiers participating in combat have been in serious blood loss and many have not survived before reaching the nearest medical facility.

"The purpose of XStat is to improve first-aid when patients with bleeding are not able to get to medical facilities," said Andrew Barofsky, CEO of RevMedx. In addition, William Maisel, a senior FDA official, also added: "We are very excited to see this technology applied to life in order to help people control the death of patients. too much blood loss " . Although highly appreciated, the FDA itself recommends that XStat is not suitable for injuries occurring in some dangerous areas such as the chest, pelvis, abdomen or above the collarbone.